Frontiers in Oncology | Pediatric Oncology

Original Research

Published on 09 Oct 2020

Outcome of Acute Respiratory Failure Secondary to Engraftment in Children After Hematopoietic Stem Cell Transplant

in Pediatric Oncology

Lama Elbahlawan
Ray Morrison
Ying Li
Sujuan Huang
Cheng Cheng
Yvonne Avent
Renee Madden

Frontiers in Oncology

doi 10.3389/fonc.2020.584269

4,600 views
12 citations

Original Research

Published on 02 Oct 2020

Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma

in Pediatric Oncology

Akihiro Tamura
Shotaro Inoue
Takeshi Mori
Jun Noguchi
Sayaka Nakamura
Atsuro Saito
Aiko Kozaki
Toshiaki Ishida
Kay Sadaoka
Daiichiro Hasegawa

Frontiers in Oncology

doi 10.3389/fonc.2020.572413

6,330 views
4 citations

Review

Published on 16 Sep 2020

How We Treat Fever and Hypotension in Pediatric Hematopoietic Cell Transplant Patients

in Pediatric Oncology

Matt S. Zinter
Christopher C. Dvorak
Jeffery J. Auletta

Frontiers in Oncology

doi 10.3389/fonc.2020.581447

6,458 views
2 citations

Review

Published on 09 Sep 2020

Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Stem Cell Transplantation

in Pediatric Oncology

Kimberly Fan
Jennifer McArthur
R. Ray Morrison
Saad Ghafoor

Frontiers in Oncology

doi 10.3389/fonc.2020.01757

12,380 views
28 citations

Original Research

Published on 06 Aug 2020

A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas

in Pediatric Oncology

Ida Russo
Virginia Di Paolo
Alessandro Crocoli
Angela Mastronuzzi
Annalisa Serra
Pier Luigi Di Paolo
Angela Di Giannatale
Evelina Miele
Giuseppe Maria Milano

Frontiers in Oncology

doi 10.3389/fonc.2020.01228

4,677 views
17 citations

Original Research

Published on 05 Aug 2020

Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities

in Pediatric Oncology

Avis Harden
Dristhi Ragoonanan
Daryl Anildes-Gubman
David McCall
Kathleen Faltus
Sarah Featherston
Basirat Shoberu
Jerelyn R. Moffet
Demetrios Petropoulos
Sajad J. Khazal

Frontiers in Oncology

doi 10.3389/fonc.2020.01227

4,249 views
4 citations

Original Research

Published on 17 Jul 2020

Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia

in Pediatric Oncology

Monika Lejman
Monika Włodarczyk
Borys Styka
Agata Pastorczak
Joanna Zawitkowska
Joanna Taha
Łukasz Sędek
Katarzyna Skonieczka
Marcin Braun
Olga Haus

Frontiers in Oncology

doi 10.3389/fonc.2020.01184

16,294 views
10 citations

Mini Review

Published on 16 Jul 2020

Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia

in Pediatric Oncology

Shannon E. Conneely
Stacy L. Cooper
Rachel E. Rau

Frontiers in Oncology

doi 10.3389/fonc.2020.01129

26,882 views
26 citations

Original Research

Published on 03 Jun 2020

Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study

in Pediatric Oncology

Federica Garibotto
Francesca Madia
Claudia Milanaccio
Antonio Verrico
Arnoldo Piccardo
Domenico Tortora
Gianluca Piatelli
Maria Cristina Diana
Valeria Capra
Maria Luisa Garrè

Frontiers in Oncology

doi 10.3389/fonc.2020.00795

7,555 views
15 citations

Original Research

Published on 02 Jun 2020

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma

in Pediatric Oncology

Jianhao Li
Benchen Rao
Jie Yang
Liwen Liu
Maoxin Huang
Xin Liu
Guangying Cui
Chao Li
Qicai Han
Hao Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.00769

10,583 views
81 citations

Original Research

Published on 27 May 2020

Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma

in Pediatric Oncology

Jacob Bellamy
Marianna Szemes
Zsombor Melegh
Anthony Dallosso
Madhu Kollareddy
Daniel Catchpoole
Karim Malik

Frontiers in Oncology

doi 10.3389/fonc.2020.00818

8,675 views
19 citations

Original Research

Published on 05 May 2020

Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients

in Pediatric Oncology

Talita Ferreira Marques Aguiar
Maria Prates Rivas
Silvia Costa
Mariana Maschietto
Tatiane Rodrigues
Juliana Sobral de Barros
Anne Caroline Barbosa
Renan Valieris
Gustavo R. Fernandes
Debora R. Bertola

Frontiers in Oncology

doi 10.3389/fonc.2020.00556

7,916 views
15 citations

Mini Review

Published on 21 Apr 2020

Mini-Review on Targeted Treatment of Desmoplastic Small Round Cell Tumor

in Pediatric Oncology

Tomas S. Bexelius
Ajla Wasti
Julia C. Chisholm

Frontiers in Oncology

doi 10.3389/fonc.2020.00518

18,069 views
29 citations

Review

Published on 03 Apr 2020

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma

in Pediatric Oncology

Harriet E. D. Southgate
Lindi Chen
Nicola J. Curtin
Deborah A. Tweddle

Frontiers in Oncology

doi 10.3389/fonc.2020.00371

9,550 views
32 citations

Original Research

Published on 24 Mar 2020

Abnormal Vital Signs Predict Critical Deterioration in Hospitalized Pediatric Hematology-Oncology and Post-hematopoietic Cell Transplant Patients

in Pediatric Oncology

Asya Agulnik
Jeffrey Gossett
Angela K. Carrillo
Guolian Kang
R. Ray Morrison

Frontiers in Oncology

doi 10.3389/fonc.2020.00354

10,542 views
26 citations

Original Research

Published on 06 Mar 2020

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

in Pediatric Oncology

Robyn T. Sussman
Jo Lynne Rokita
Kevin Huang
Pichai Raman
Komal S. Rathi
Daniel Martinez
Kristopher R. Bosse
Maria Lane
Lori S. Hart
Tricia Bhatti

Frontiers in Oncology

doi 10.3389/fonc.2020.00302

6,669 views
14 citations

Mini Review

Published on 03 Mar 2020

Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are

in Pediatric Oncology

Mattia Saggioro
Edoardo D'Angelo
Gianni Bisogno
Marco Agostini
Michela Pozzobon

Frontiers in Oncology

doi 10.3389/fonc.2020.00076

7,932 views
28 citations

Mini Review

Published on 28 Feb 2020

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy

in Pediatric Oncology

Rebecca Epperly
Stephen Gottschalk
M. Paulina Velasquez

Frontiers in Oncology

doi 10.3389/fonc.2020.00262

17,354 views
79 citations

Mini Review

Published on 25 Feb 2020

Bone Marrow Senescence and the Microenvironment of Hematological Malignancies

in Pediatric Oncology

Charlotte Hellmich
Jamie A. Moore
Kristian M. Bowles
Stuart A. Rushworth

Frontiers in Oncology

doi 10.3389/fonc.2020.00230

9,484 views
30 citations

Review

Published on 21 Feb 2020

Exercise as a Potential Intervention to Modulate Cancer Outcomes in Children and Adults?

in Pediatric Oncology

Sabine Kesting
Peter Weeber
Martin Schönfelder
Bernhard W. Renz
Henning Wackerhage
Irene von Luettichau

Frontiers in Oncology

doi 10.3389/fonc.2020.00196

8,784 views
14 citations

Review

Published on 18 Feb 2020

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

in Pediatric Oncology

Yoko Tabe
Marina Konopleva
Michael Andreeff

Frontiers in Oncology

doi 10.3389/fonc.2020.00155

16,538 views
66 citations

Review

Published on 14 Feb 2020

Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment

in Pediatric Oncology

Jill Nehrbas
John T. Butler
Ding-Wen Chen
Peter Kurre

Frontiers in Oncology

doi 10.3389/fonc.2020.00090

12,368 views
48 citations

Review

Published on 07 Feb 2020

Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma

in Pediatric Oncology

T. A. Kluiver
M. Alieva
D. G. van Vuurden
Ellen J. Wehrens
Anne C. Rios

Frontiers in Oncology

doi 10.3389/fonc.2020.00092

12,547 views
34 citations

Review

Published on 21 Jan 2020

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies

in Pediatric Oncology

Thomas Kent
Deanne Gracias
Samuel Shepherd
David Clynes

Frontiers in Oncology

doi 10.3389/fonc.2019.01518

14,652 views
28 citations

648 articles

articles

Outcome of Acute Respiratory Failure Secondary to Engraftment in Children After Hematopoietic Stem Cell Transplant

Low Multiplication Value of Absolute Monocyte Count and Absolute Lymphocyte Count at Diagnosis May Predict Poor Prognosis in Neuroblastoma

How We Treat Fever and Hypotension in Pediatric Hematopoietic Cell Transplant Patients

Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Stem Cell Transplantation

A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas

Chimeric Antigen Receptor, Teamwork, Education, Assessment, and Management (CAR-TEAM): A Simulation-Based Inter-professional Education (IPE) Intervention for Management of CAR Toxicities

Advantages and Limitations of SNP Array in the Molecular Characterization of Pediatric T-Cell Acute Lymphoblastic Leukemia

Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia

Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study

Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma

Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma

Insights Into the Somatic Mutation Burden of Hepatoblastomas From Brazilian Patients

Mini-Review on Targeted Treatment of Desmoplastic Small Round Cell Tumor

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma

Abnormal Vital Signs Predict Critical Deterioration in Hospitalized Pediatric Hematology-Oncology and Post-hematopoietic Cell Transplant Patients

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy

Bone Marrow Senescence and the Microenvironment of Hematological Malignancies

Exercise as a Potential Intervention to Modulate Cancer Outcomes in Children and Adults?

Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML

Extracellular Vesicles and Chemotherapy Resistance in the AML Microenvironment

Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma

Alternative Lengthening of Telomeres in Pediatric Cancer: Mechanisms to Therapies